Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Smith and Nephew plc
Smith and Nephew plc
Activities:
Personal Protection
Manufacturing
Ingredients
Medical Devices
X
LinkedIn
Trending Articles
Counteracting counterfeits in the pharmaceutical supply chain
Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m
Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases
Olon commits to ultra-potent compound manufacturing expansion with new €25m facility
The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
CDMO PCI Pharma Services wins a US Supply Chain Excellence Award
The company was acknowledged for its digital clinical trial and commercial lifespan management solution, pci I bridge
New kinase inhibitor shows promise for treatment-resistant malaria
The single-dose drug may be more effective than current treatments on the market, and works by disabling Plasmodium's ability to splice RNA
Upcoming event
CPhI India
26–28 November 2024 | Online Conference & Networking | Delhi, India
See all
Related Content
Manufacturing
Smith & Nephew grows surgical robotics offering
The British medical technology company has invested in its digital surgery portfolio through the acquisition of Brainlab’s Orthopaedic Joint Reconstruction business and the opening of a new R&D centre
Finance
Smith & Nephew acquires Osiris to focus on regenerative medicine
The companies expect to close the transaction in the second quarter of 2019, subject to customary closing conditions
Recruitment
Smith and Nephew appoints Namal Nawana CEO
Finance
Graham Baker appointed Chief Financial Officer
Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Graham Baker as Chief Financial Officer.
Subscribe now